These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 15694137

  • 1. Microvessel density in muscles of dogs with golden retriever muscular dystrophy.
    Nguyen F, Guigand L, Goubault-Leroux I, Wyers M, Cherel Y.
    Neuromuscul Disord; 2005 Feb; 15(2):154-63. PubMed ID: 15694137
    [Abstract] [Full Text] [Related]

  • 2. Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies.
    Nguyen F, Cherel Y, Guigand L, Goubault-Leroux I, Wyers M.
    J Comp Pathol; 2002 Feb; 126(2-3):100-8. PubMed ID: 11944998
    [Abstract] [Full Text] [Related]

  • 3. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
    Yuasa K, Nakamura A, Hijikata T, Takeda S.
    BMC Musculoskelet Disord; 2008 Jan 09; 9():1. PubMed ID: 18182116
    [Abstract] [Full Text] [Related]

  • 4. Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog.
    Zucconi E, Valadares MC, Vieira NM, Bueno CR, Secco M, Jazedje T, da Silva HC, Vainzof M, Zatz M.
    Neuromuscul Disord; 2010 Jan 09; 20(1):64-70. PubMed ID: 19944604
    [Abstract] [Full Text] [Related]

  • 5. Ringo, a Golden Retriever Muscular Dystrophy (GRMD) dog with absent dystrophin but normal strength.
    Ambrósio CE, Valadares MC, Zucconi E, Cabral R, Pearson PL, Gaiad TP, Canovas M, Vainzof M, Miglino MA, Zatz M.
    Neuromuscul Disord; 2008 Nov 09; 18(11):892-3. PubMed ID: 18667316
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.
    Kornegay JN, Bogan DJ, Bogan JR, Dow JL, Wang J, Fan Z, Liu N, Warsing LC, Grange RW, Ahn M, Balog-Alvarez CJ, Cotten SW, Willis MS, Brinkmeyer-Langford C, Zhu H, Palandra J, Morris CA, Styner MA, Wagner KR.
    Skelet Muscle; 2016 Nov 09; 6():14. PubMed ID: 27047655
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Golden retriever muscular dystrophy (GRMD): Developing and maintaining a colony and physiological functional measurements.
    Kornegay JN, Bogan JR, Bogan DJ, Childers MK, Grange RW.
    Methods Mol Biol; 2011 Nov 09; 709():105-23. PubMed ID: 21194024
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of prednisone in canine muscular dystrophy.
    Liu JM, Okamura CS, Bogan DJ, Bogan JR, Childers MK, Kornegay JN.
    Muscle Nerve; 2004 Dec 09; 30(6):767-73. PubMed ID: 15468337
    [Abstract] [Full Text] [Related]

  • 13. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
    Fukushima K, Nakamura A, Ueda H, Yuasa K, Yoshida K, Takeda S, Ikeda S.
    BMC Musculoskelet Disord; 2007 Jun 28; 8():54. PubMed ID: 17598883
    [Abstract] [Full Text] [Related]

  • 14. Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs.
    Nghiem PP, Hoffman EP, Mittal P, Brown KJ, Schatzberg SJ, Ghimbovschi S, Wang Z, Kornegay JN.
    Am J Pathol; 2013 Nov 28; 183(5):1411-24. PubMed ID: 24160322
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Muscular dystrophy in dogs: does the crossing of breeds influence disease phenotype?
    Miyazato LG, Moraes JR, Beretta DC, Kornegay JN.
    Vet Pathol; 2011 May 28; 48(3):655-62. PubMed ID: 21233328
    [Abstract] [Full Text] [Related]

  • 17. Tarsal joint contracture in dogs with golden retriever muscular dystrophy.
    Kornegay JN, Sharp NJ, Schueler RO, Betts CW.
    Lab Anim Sci; 1994 Aug 28; 44(4):331-3. PubMed ID: 7983843
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle.
    Martin PT, Golden B, Okerblom J, Camboni M, Chandrasekharan K, Xu R, Varki A, Flanigan KM, Kornegay JN.
    PLoS One; 2014 Aug 28; 9(2):e88226. PubMed ID: 24505439
    [Abstract] [Full Text] [Related]

  • 20. Physical therapy assessment tools to evaluate disease progression and phenotype variability in Golden Retriever muscular dystrophy.
    Gaiad TP, Silva MB, Silva GC, Caromano FA, Miglino MA, Ambrósio CE.
    Res Vet Sci; 2011 Oct 28; 91(2):188-93. PubMed ID: 21315399
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.